Corneal Staining
9
0
0
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
44%
4 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (9)
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye
Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose Solutions
A Clinical Comparison of Marketed Lens Care Solutions With Avaira Lens Brand
Clinical Evaluation of Opti-Free III (FID 109182) Compared to Opti-Free Plus® in Japan
Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining
Comfort Evaluation of a New MPS vs. Replenish in Contact Lens Patients
Evaluation of Corneal Staining With Various Contact Lens/Solution Combinations
Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining